Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00090
|
|||||
| EM Name |
Glutamate
|
|||||
| Synonyms |
L-glutamic acid; GLUTAMIC ACID; (2S)-2-Aminopentanedioic acid; H-Glu-OH; (S)-2-Aminopentanedioic acid; Glutaminol; L-Glutaminic acid; glutacid; Glutamidex; Glutamicol; Glutaton; Glusate; Aciglut; glutaminic acid; (S)-Glutamic acid; L-glutamate; L-glu; D-Glutamiensuur; Acidum glutamicum; Poly-L-glutamate; L-(+)-glutamic acid; alpha-aminoglutaric acid; L-2-Aminoglutaric acid; POLYGLUTAMIC ACID; Acido glutamico; Glutamic acid polymer; Acide glutamique; 1-Aminopropane-1,3-dicarboxylic acid; Acidum glutaminicum; glut
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=33032"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H9NO4
|
|||||
| Canonical SMILES |
C(CC(=O)O)C(C(=O)O)N
|
|||||
| InChI |
InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1
|
|||||
| InChIKey |
WHUUTDBJXJRKMK-VKHMYHEASA-N
|
|||||
| CAS Number |
CAS 56-86-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 147.13 | Topological Polar Surface Area | 101 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
-3.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:16015
|
|||||
| DT(s) "handling" This EM | EAAT2 | Transporter Info | Excitatory amino acid transporter 2 | [1] | ||
| GC1 | Transporter Info | Mitochondrial glutamate carrier 1 | [2] | |||
| MRP6 | Transporter Info | Multidrug resistance-associated protein 6 | [3] | |||
| SLC7A11 | Transporter Info | Cystine/glutamate transporter | [4] | |||
| VMAT2 | Transporter Info | Vesicular amine transporter 2 | [5] | |||
| References | ||||||
| 1 | Metabolomics Based Identification of SIRT5 and Protein Kinase C Epsilon Regulated Pathways in Brain. Front Neurosci. 2018 Jan 30;12:32. | |||||
| 2 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | |||||
| 3 | Untargeted Metabolomics Analysis of ABCC6-Deficient Mice Discloses an Altered Metabolic Liver Profile. J Proteome Res. 2016 Dec 2;15(12):4591-4600. | |||||
| 4 | The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem. 2017 Aug 25;292(34):14240-14249. | |||||
| 5 | A metabolomic study of brain tissues from aged mice with low expression of the vesicular monoamine transporter 2 (VMAT2) gene. Neurochem Res. 2008 Feb;33(2):292-300. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.